Clinical Trials on Beneficiairies Requesting a Resource Allocation (APA)
Total 1 results
-
Rennes University HospitalCompletedPersons Requesting a Resource Allocation (APA) | Beneficiairies Requesting a Resource Allocation (APA)France
Sponsors and Collaborators
- Cardresearch
- Donders Institute for Brain, Cognition and Behavior
- The Fifth Affiliated Hospital of Zunyi Medical College
- Celtaxsys Aus Pty Limited
- AMTC & Associates
- Victor Montori
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Rui-hua Xu, MD, PhD
- Societa Italiana di Endoscopia Digestiva
- Elim Pediatric Pharmaceuticals Inc.
- Norsk Proteinintolerance, Norway
- Diego Hernan Giunta, MD
- ProteoSys AG
- CRMBM-CEMEREM
- Caritas Freetown
- University Medical Center Goettingen
- Alberta Children's Hospital, Calgary, Canada
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- San MediTech(Huzhou)Co.,Ltd.
- Fondren Orthopedic Group L.L.P.
- View Full List
Medical Conditions
- Postcomatose Unawareness State
- Malignant Ascites Due to Epithelial Carcinoma
- Atrial Fibrillation, Postoperative
- Non-dystrophic Myotonias
- Fever, Sweats, and Hot Flashes
- Non-compressible Torso Hemorrhage
- Plasmodium Falciparum Malaria (Drug Resistant)
- Spermatogenesis Arrest
- Gynecologic Cancer
- Tularaemia
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Orbital Tumor
- Prostate Cancer Recurrent
- Auditory Hallucination, Verbal
- Stereotactic Radioablation for Ventricular Tachycardia
- Lymphedema of Arm
- Tube Disorders Eustachian
- Normal Diameter of Optic Nerve
- Disturbance of Activity and Attention
- Fibromyalgia Syndrome, Primary
- View Full List
Drug Interventions
- Indoximod
- Oxycodone, fentanyl
- Enzalutamide, Abiraterone
- Lamivudine
- Flibanserin 100 mg dose every evening
- Polyethylene glycol 3350
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Insulin
- Ruxolitinib
- Epimedium Prenylflavonoids Extract
- SERETIDE Diskus
- Bortezomib/dexamethasone
- Topotecan
- Atezolizumab
- Methotrexate
- Cetrorelix 78 mg + 78 mg
- Mupirocin Calcium
- PF-00868554
- Cytarabine ARA-C
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Georgia
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Hungary
- Contract Research Organizations in Iran
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mali
- Contract Research Organizations in Oman
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Türkiye
- CRO list by country